Searchable abstracts of presentations at key conferences in endocrinology

ea0041ep873 | Pituitary - Clinical | ECE2016

Comorbidities and treatment patterns among patients with acromegaly in Sweden : a register-linkage population-based study

Lesen Eva , Granfeldt Daniel , Houchard Aude , Dinet Jerome , Berthon Anthony , Bjorholt Ingela , Johannsson Gudmundur

Introduction: Treatment of patients with acromegaly is complex, including surgery, pharmacotherapy and radiotherapy. The objective was to describe comorbidities and treatment patterns among patients with acromegaly in Sweden.Methods: Population-based study including all patients with a first diagnosis of acromegaly due to a pituitary adenoma in Sweden between 1 Jul 2005 and 31 Dec 2013. Data was obtained via linkage of the National Patient Register, Swed...

ea0056p158 | Pituitary - Basic | ECE2018

Gender differences in delays to diagnosis of acromegaly: data from the Swedish National Patient Register

Granfeldt Daniel , Bjorstad AEse , Tom Marlow , Berthon Anthony , Dinet Jerome , Myrenfors Peter , Lesen Eva , Bjorholt Ingela , Olsson Daniel S. , Johannsson Gudmundur

Acromegaly is a complex disease with an insidious onset and diagnosis can be delayed. The aim of the study was to investigate the diagnostic delay (DD), for patients with acromegaly due to a pituitary tumour in Sweden. Data were obtained from the Swedish National Patient Register. Patients diagnosed between January 1, 2011 and December 31, 2013 in Sweden were included (n=135, 69 men, 66 women). For these patients, the occurrence of pre-defined relevant comorbidities w...

ea0056p159 | Pituitary - Basic | ECE2018

Direct costs after diagnosis of acromegaly: Data from Swedish nationwide registries

Granfeldt Daniel , Bjorstad AEse , Marlow Tom , Berthon Anthony , Dinet Jerome , Myrenfors Peter , Lesen Eva , Olsson Daniel S , Johannsson Gudmundur , Bjorholt Ingela

Acromegaly and comorbidities incur large costs in the Swedish health care system. The aim of the study was to describe direct costs since time of diagnosis, for patients with acromegaly due to a pituitary tumour in Sweden. Data were obtained via linkage of nationwide registers. Patients diagnosed between 1 July 2005 and 31 December 2007 in Sweden and with a follow-up of at least 6 years were included (n=105). Direct costs due to use of health care resources and pharma...